Dana-Farber Cancer Institute, Inc.

Boston, MA   |  www.dana-farber.org

Mission

Founded in 1947, Dana-Farber Cancer Institute's mission is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations and disseminates innovative patient therapies and scientific discoveries in Boston, across the United States and throughout the world.

Ruling year info

1962

President and Chief Executive Officer

Dr. Laurie H. Glimcher

Main address

450 Brookline Avenue

Boston, MA 02215 USA

Show more contact info

Formerly known as

Children's Cancer Research Foundation

Sidney Farber Cancer Center

EIN

04-2263040

NTEE code info

Hospitals and Primary Medical Care Facilities (E20)

Hospitals and Primary Medical Care Facilities (E20)

Fund Raising and/or Fund Distribution (E12)

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Sign in or create an account to view Form(s) 990 for 2019, 2018 and 2017.
Register now

Programs and results

What we aim to solve

This profile needs more info.

If it is your nonprofit, add a problem overview.

Login and update

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

A. Patient Care

Dana-Farber provides outpatient care to adult patients in 13 specialized centers and partners with Brigham and Women's Hospital to provide inpatient care. Pediatric patients receive outpatient care at our Jimmy Fund Clinic and inpatient care is provided by Children's Hospital Boston.

Population(s) Served
Adults
Children and youth

Research, both basic and clinical, remains at the core of our mission. Our researchers are currently trailblazing the concept of personalized medicine, tailoring therapies to each patient, to develop less invasive and toxic treatments.

Population(s) Served
Adults

A teaching affiliate of Harvard Medical School, DFCI supports participation by its professional staff in medical education, clinical training, and pre-doctoral and post-doctoral research training.

Population(s) Served
Adults

Dana-Farber promotes health in the Greater Boston community through its Community Benefits Program, which brings cancer education & resources to at-risk populations, and through its Center for Community-Based Research, which conducts research to reduce disparities in cancer care.

Population(s) Served
Adults

Where we work

Financials

Dana-Farber Cancer Institute, Inc.
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

Dana-Farber Cancer Institute, Inc.

Board of directors
as of 6/16/2021
SOURCE: Self-reported by organization
Board chair

Mr. Joshua Bekenstein

Bain Capital Partners, LLC

Term: 2011 -

Andrea Abraham

n/a

Gerhard Andlinger

Andlinger & Co.

Michael Andrews

n/a

David Auerbach

n/a

David Barrett

Polaris Venture Partners

Robert Belfer

Belfer Management LLC

Edward Benz

Dana-Farber Cancer Institute

Roger Berkowitz

Legal Sea Foods

Amy Smith Berylson

Chestnut Hill Ventures

Armin Biller

n/a

Jack Blais

BlaisCo, LLC

Betty Ann Blum

n/a

Stephen Breyer

Supreme Court of The United States

Frederick Brown

Massachusetts Appeals Court

J. Gary Burkhead

n/a

Kennett Burnes

n/a

Stephen Burton

CBS4

Richard Cantor

Cantor Foundation

Michael Champa

n/a

George Cloutier

American Management Services

Marc Cohen

OPNET Technologies

Joseph Cotter

n/a

Gary Countryman

Liberty Mutual Insurance Companies

Howard Cox

Greylock

Neal Curtin

Bingham McCutchen, LLP

Alice Cutler

n/a

Charles Dana

Newport Shipyard Corporation

Lee Daniels

n/a

Nader Darehshori

n/a

Laura Weissman Davis

n/a

David Dechman

Summit Rock Advisors

Peter de Roetth

Account Management, LLC

Emily DiMaggio

n/a

Jim Donovan

Goldman Sachs Corp.

James Dow

n/a

John Dunfey

New Hampshire Charitable Foundation

Donald Dwares

n/a

Michael Eisenson

Charlesbank Capital Partners, LLC

Ed Eskandarian

Arnold Worldwide Partners

John Farber

Old Trail School

Stephen Farber

Concordia Group

Thomas Farrington

Prostate Health Education Network, Inc.

James Fine

Levy & Droney P.C.

Stephen Fine

The Biltrite Corporation

Robert First

n/a

Deborah First

Deborah First Communications

Charles Forman

n/a

Emil Frei

n/a

Michael Frieze

Gordon Brothers Group

Dozier Gardner

Fernwood Advisors

Arthur Gelb

Four Sigma Corporation

Nancy Gibson

n/a

William Gillen

Eaton Vance Investment Counsel

Michael Gordon

Vinik Asset Management

Abraham Gosman

n/a

James Griffin

Dana-Farber Cancer Institute

Richard Grubman

Highfields Capital Management

Judy Hale

Granite Telecommunications LLC

David Harkins

Thomas H. Lee Partners, LP

Marian Heard

n/a

Frances Heller

n/a

Alan Hirschfield

Norman Hirschfield & Co.

Thomas Holt

K&L Gates

Barbara Hugus

n/a

Alison Poorvu Jaffe

n/a

Jane Jamieson

n/a

Glenn Johnson

Northland Investment Corporation

Scott Kafker

Massachusetts Appeals Court

William Karol

Koda Enterprises Group, LLC

Stephen Kay

Goldman, Sachs, & Company

Patricia Kelsey

n/a

Michelle Kessler

n/a

Michael Kittredge

n/a

Brian Knez

Castanea Partners

Ruth Kopelman

n/a

Steven Koppel

n/a

Paul Kopperl

n/a

Stephen Koster

Vacovec, Mayotte & Singer, LLP

Daniel Kraft

International Forest Products

Robert Kraft

The Kraft Group

Sandra Krakoff

n/a

Phyllis Krock

n/a

Althea Lank

n/a

Rebecca Latimore

IBM Institute For Business Value

Jonathan Lavine

Bain Capital Partners, LLC

Kenneth Leet

Granite Ridge LLP

John Legere

n/a

Kenneth Levine

Seaview Consulting, Inc.

Roger Lockwood

Lockwood/McKinnon Group

Richard Lubin

Berkshire Partners, LLC

Bradley Lucas

Anton Lucas, Inc.

Larry Lucchino

Boston Red Sox

Hildegarde Mahoney

Harvard Mahoney Neuroscience Inst.

Peter Maich

n/a

Roger Marino

Marino Capital Corp

John Marshall

Marshall Properties, Inc.

Thomas May

NSTAR

William McCall

McCall & Almy Inc.

Joseph McNay

Essex Investment Mgmt. Co., Inc.

William Meagher

n/a

David Moross

Falconhead Capital

Richard Morse

n/a

David Nathan

Dana-Farber Cancer Institute

George Neale

Liberty Mutual Insurance Companies

Charlie Nirenberg

First Merchants Group

Joseph Norberg

n/a

John O'Connor

n/a

Brian O'Connor

Miles Logue Financial Group

Vincent O'Reilly

Boston College

Stuart Orkin

Dana-Farber Cancer Institute

Edward Owens

Owens Companies, Inc.

Peter Palandjian

Intercontinental Real Estate Corp.

Arthur Pappas

UMass Medical School

Ted Pasquarello

Paris Trust LLC

Jean Pearlstein

n/a

David Perini

n/a

Eileen Perini

n/a

Jennifer Perini

Everyman Pictures

Steven Perlmutter

Robinson & Cole

Susan Poduska

Poduska Family Foundation

Betsy Pohl

MFS Investment Management

William Poutsiaka

Chartis Insurance

Kathleen Randolph

n/a

John Randolph

n/a

Jim Rappaport

New Boston Fund, Inc.

John Reardon

Harvard

Sumner Redstone

National Amusements, Inc.

Shari Redstone

National Amusements, Inc.

Amy Reiner

n/a

Robert Reynolds

Putnam Investments

Barrett Rollins

Dana-Farber Cancer Institute

Ann Rosenberg

D'Vine Wine

Harvey Rosenthal

n/a

Edward Rover

Charles A. Dana Foundation

Robert Sachs

Continental Consulting Group, LLC

Barbara Sadowsky

n/a

James Sadowksy

Williams Distributing Corporation

Stephen Sallan

Dana-Farber Cancer Institute

Marjorie Salmon

Assoc. Counselors and Psychotherapists

Malcolm Salter

Harvard Business School

H. Terrence Samway

n/a

Rebecca Sanders

Destin Realty, Inc.

Judith Schlager

The Bullfinch Companies, Inc.

Richard Seaman

Seaman Corporation

Thomas Sellers

n/a

Laura Jeanne Sen

BJ's Wholesale Club Incorporated

Paul Severino

n/a

Jean Sharf

Sharf Marketing Group, Inc.

Paula Sidman

The Beacon Companies

Susan Smith

n/a

Richard Smith

Smith Management Company

Ruth Snider

n/a

Jerry Socol

The Socol Group

Gloria Spivak

n/a

Robert Stansky

Fidelity Investments

William Starr

Pan Mass Challenge

James Stoneman

Seljim Investments

Patrick Sullivan

Game Creek Video LLC

Fifi Swerling Kellem

Dana-Farber Cancer Institute

Jean Tempel

First Light Capital

Beth Terrana

n/a

David Ting

Mugar Enterprises, Inc.

Delores Barr Weaver

n/a

J. Wayne Weaver

n/a

Karen Webster

Market Platform Dynamics

T. Conrad Wetterau

Quality Beverage Co.

Gregory White

Thomas H. Lee Partners, LP

Frederica Williams

Whittier Street Health Center

Winnie Wong

n/a

Carl Yastrzemski

Eaton Vance Investment Counsel

Jay Yost

Fidelity Investments

Mortimer Zuckerman

Boston Properties

Craig Bunnell

Dana-Farber Cancer Institute

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? No
  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? No
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? No
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? No
  • Board performance
    Has the board conducted a formal, written self-assessment of its performance within the past three years? No